PTC Therapeutics, Inc.
PTCT
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutā¦ read more
Healthcare
Biotechnology
12 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$68.56
Price+0.23%
$0.16
1Y
Price
Market Cap
$5.675b
Mid
Price/Earnings 3y Avg5y Avg
8x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-43.1%
EBITDA Margin-82.0%
Net Profit Margin-22.2%
Free Cash Flow Margin-43.1%
EBITDA Margin-82.0%
Net Profit Margin-22.2%
Free Cash Flow MarginRevenue
$1.731b
+114.5%
1y CAGR+44.9%
3y CAGR+41.1%
5y CAGREarnings
$682.644m
+287.9%
1y CAGR+105.9%
3y CAGR+77.8%
5y CAGREPS
$7.78
+263.6%
1y CAGR+99.9%
3y CAGR+73.7%
5y CAGRBook Value
-$205.313m
$2.911b
Assets$3.117b
Liabilities$492.281m
DebtDebt to Assets
16.9%
0.5x
Debt to EBITDAFree Cash Flow
$702.336m
+484.1%
1y CAGR+188.0%
3y CAGR+128.2%
5y CAGRNo items found.
Press Releases
Statements and updates from the company